Skip to main content
China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
0.320
-0.020 (-5.91%)
At close: Dec 20, 2024, 4:00 PM
0.344
+0.024 (7.50%)
After-hours: Dec 20, 2024, 7:52 PM EST

China SXT Pharmaceuticals Revenue

In the fiscal year ending March 31, 2024, China SXT Pharmaceuticals had annual revenue of $1.93M, down -2.19%. China SXT Pharmaceuticals had revenue of $988.91K in the half year ending March 31, 2024, a decrease of -37.20%.

Revenue (ttm)
$1.93M
Revenue Growth
-2.19%
P/S Ratio
0.14
Revenue / Employee
$25,713
Employees
75
Market Cap
1.11M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20241.93M-43.18K-2.19%
Mar 31, 20231.97M-630.60K-24.23%
Mar 31, 20222.60M-2.18M-45.53%
Mar 31, 20214.78M-384.70K-7.45%
Mar 31, 20205.16M-1.85M-26.38%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

SXTC News

More News